Ola Electric to raise up to ₹1,700 crore via NCDs and other debt instruments Retail investors drive Unified Data-Tech Solutions IPO to 2.3x subscription on day one Canadian dollar steadies ahead of retail sales data NY Fed’s Perli Sees Early Signs of Pressure in Money Markets Stocks to Watch: शुक्रवार को फोकस में रहेंगे ये 14 स्टॉक्स, दिख सकती है बड़ी हलचल Stocks to Watch: Sun Pharma, Ramco Cements, Grasim Industries, CONCOR and more Delhi-Srinagar IndiGo Flight Turbulence: Hailstorm-hit flight lands safely, passengers safe; 'near-death experience', says TMC leader BSE Sensex में बड़े बदलाव: Trent, BEL करेंगी एंट्री; इन कंपनियों की होगी विदाई
News Image

Q4 results live: Grasim Industries loss narrows, revenue rises; CONCOR board approves bonus issue

Published on: May 22, 2025, 9:11 pm

Source: CNBCTV18

Mtar Tech Q4 Result

Grasim Industries Q4 Results

Ramco Cements Q4 Results

CONCOR Q4 Earnings

Metro Brands Q4 Results

Gujarat State Petronet Q4 Results

Power Mech Q4 Results

HFCL Q4 Results

ITC Q4 Earnings

Sun Pharmaceutical Industries reported a mixed set of numbers for the March quarter, with net profit declining 19% year-on-year to ₹2,153.9 crore—missing CNBC-TV18’s poll estimate of ₹2,934 crore. Revenue, however, rose 8.1% YoY to ₹12,958.8 crore, broadly in line with expectations.

The company’s EBITDA grew 22.4% YoY to ₹3,715.9 crore, with margins improving to 28.7% from 25.3% in the same quarter last year. Sun Pharma’s board recommended a final dividend of ₹5.50 per equity share. More deets here.

Honasa Consumer Q4 Results

Udaipur Cement Q4 Results

Kirloskar Industries Q4 Results

Dwarikesh Sugar Q4 results

Deepak Fertilisers And Petrochemicals Corporation Q4 Results

Sandhar Q4 Results

Subros Q4 Results

Indoco Remedies Q4 results

Emcure Pharma Q4 Results     

Barbeque Nation Q4 Results

Strides Pharma reported a net profit of ₹85.6 crore for Q4, up sharply from ₹10.4 crore a year ago, aided by a 23% jump in US revenues to $77 million. Overall Q4 revenue rose 14% YoY to ₹1,190 crore.

The company’s FY25 revenue growth stood at 17.2%—ahead of its 12–15% guidance—while EBITDA came in at ₹802.8 crore. Net debt was reduced by ₹512.8 crore, improving the Net Debt-to-EBITDA ratio to 1.9x. Management credited operational efficiency and margin resilience post-demerger for the strong showing. More deets here

Good luck India Q4 Results 

Bajel Projects Q4 Results

Strides Pharma Q4 Results

Shares of Fortis Healthcare Ltd. are trading with gains of as much as 10% on Thursday, May 22, after the Gurgaon-headquartered healthcare company’s steady Q4 performance.

– Net Profit Up 5.7% at ₹74 Cr Vs ₹70 Cr (YoY)

– Revenue Up 15.8% at ₹264 Cr Vs ₹228 Cr (YoY)

– EBITDA Up 10.6% at ₹105 Cr Vs ₹95 Cr (YoY)

– Margin At 39.8% Vs 41.7% (YoY)

VRL Logistics shares climbed nearly 13% on Thursday, May 22, after the company reported a big margin jump in its fourth quarter earnings. VRL Logistics’ margin in the March quarter expanded to 23.1% from 13.7% in the year-ago period.

Let's Connect with CNBCTV 18

Network 18 Group :

©TV18 Broadcast Limited. All rights reserved.

© Copyright 2025 Stock Gram. All Rights Reserved.

     Privacy Policy